Joel Brooks

This profile gathers the share dealings of Joel Brooks across 2 companies, led by Cantaloupe, Inc. and Eloxx Pharmaceuticals, Inc. The record holds 21 filings, for trades running from 19 May 2005 to 16 October 2019.

On the open market, the record shows 6 purchases worth €27k and 2 sales worth €7,836. Netting one side against the other leaves €19k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 11 share grants.

The median purchase comes to €4,631. Ninety days after publication, 6 purchases show a median change of -13.1%, with the price up in 0% of them. They describe history only and say nothing certain about the share price ahead.

Most recently, on 22 November 2019, the filings show a share grant in Cantaloupe, Inc. The last purchase on record was published on 25 May 2012, which is 5,281 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.